282 related articles for article (PubMed ID: 30375237)
1. Fundamental causes of barriers to participation in Alzheimer's clinical research among African Americans.
Lincoln KD; Chow T; Gaines BF; Fitzgerald T
Ethn Health; 2021 May; 26(4):585-599. PubMed ID: 30375237
[No Abstract] [Full Text] [Related]
2. Black Americans' Perspectives of Barriers and Facilitators of Community Screening for Kidney Disease.
Umeukeje EM; Wild MG; Maripuri S; Davidson T; Rutherford M; Abdel-Kader K; Lewis J; Wilkins CH; Cavanaugh K
Clin J Am Soc Nephrol; 2018 Apr; 13(4):551-559. PubMed ID: 29545381
[TBL] [Abstract][Full Text] [Related]
3. Cancer fear and fatalism: how African American participants construct the role of research subject in relation to clinical cancer research.
Somayaji D; Cloyes KG
Cancer Nurs; 2015; 38(2):133-44. PubMed ID: 24945262
[TBL] [Abstract][Full Text] [Related]
4. Sociocultural Influences on African Americans' Representations of Type 2 Diabetes: A Qualitative Study.
Shiyanbola OO; Ward E; Brown C
Ethn Dis; 2018; 28(1):25-32. PubMed ID: 29467563
[TBL] [Abstract][Full Text] [Related]
5. Understanding Barriers and Facilitators to Signing Up for a Mobile-Responsive Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer's Disease Prevention Studies.
Neffa-Creech D; Aggarwal R; Stowell C; Menon U; George S; Plant A; Langbaum JB
J Prev Alzheimers Dis; 2023; 10(4):865-874. PubMed ID: 37874109
[TBL] [Abstract][Full Text] [Related]
6. African Americans and Clinical Research: Evidence Concerning Barriers and Facilitators to Participation and Recruitment Recommendations.
Hughes TB; Varma VR; Pettigrew C; Albert MS
Gerontologist; 2017 Apr; 57(2):348-358. PubMed ID: 26553736
[TBL] [Abstract][Full Text] [Related]
7. Perceptions, knowledge, incentives, and barriers of brain donation among African American elders enrolled in an Alzheimer's research program.
Lambe S; Cantwell N; Islam F; Horvath K; Jefferson AL
Gerontologist; 2011 Feb; 51(1):28-38. PubMed ID: 20679141
[TBL] [Abstract][Full Text] [Related]
8. Barriers and facilitators of African American participation in Alzheimer disease biomarker research.
Williams MM; Scharff DP; Mathews KJ; Hoffsuemmer JS; Jackson P; Morris JC; Edwards DF
Alzheimer Dis Assoc Disord; 2010; 24 Suppl(Suppl):S24-9. PubMed ID: 20711059
[TBL] [Abstract][Full Text] [Related]
9. A qualitative study of recruitment barriers, motivators, and community-based strategies for increasing clinical trials participation among rural and urban populations.
Friedman DB; Foster C; Bergeron CD; Tanner A; Kim SH
Am J Health Promot; 2015; 29(5):332-8. PubMed ID: 24670073
[TBL] [Abstract][Full Text] [Related]
10. A Mini-Review of Strategies for Recruiting Older African Americans to Alzheimer's Disease Research.
Esiaka D; Yarborough CC; Fausto BA; Gluck MA
Community Health Equity Res Policy; 2024 Jul; 44(4):419-428. PubMed ID: 36120808
[TBL] [Abstract][Full Text] [Related]
11. Utilizing the common sense model to explore African Americans' perception of type 2 diabetes: A qualitative study.
Shiyanbola OO; Ward EC; Brown CM
PLoS One; 2018; 13(11):e0207692. PubMed ID: 30462704
[TBL] [Abstract][Full Text] [Related]
12. Knowledge and Attitudes in Alzheimer's Disease in a Cohort of Older African Americans and Caucasians.
Howell JC; Soyinka O; Parker M; Jarrett TL; Roberts DL; Dorbin CD; Hu WT
Am J Alzheimers Dis Other Demen; 2016 Jun; 31(4):361-7. PubMed ID: 26646115
[TBL] [Abstract][Full Text] [Related]
13. Gain versus loss-framed messaging and colorectal cancer screening among African Americans: A preliminary examination of perceived racism and culturally targeted dual messaging.
Lucas T; Hayman LW; Blessman JE; Asabigi K; Novak JM
Br J Health Psychol; 2016 May; 21(2):249-67. PubMed ID: 26333060
[TBL] [Abstract][Full Text] [Related]
14. Improving diversity in study participation: Patient perspectives on barriers, racial differences and the role of communities.
Shea L; Pesa J; Geonnotti G; Powell V; Kahn C; Peters W
Health Expect; 2022 Aug; 25(4):1979-1987. PubMed ID: 35765232
[TBL] [Abstract][Full Text] [Related]
15. Differences between African Americans and Whites in their attitudes toward genetic testing for Alzheimer's disease.
Hipps YG; Roberts JS; Farrer LA; Green RC
Genet Test; 2003; 7(1):39-44. PubMed ID: 12820701
[TBL] [Abstract][Full Text] [Related]
16. Recruitment of Older African Americans in Alzheimer's Disease Clinical Trials Using a Community Education Approach.
Shaw AR; Perales-Puchalt J; Moore T; Weatherspoon P; Robinson M; Hill CV; Vidoni ED
J Prev Alzheimers Dis; 2022; 9(4):672-678. PubMed ID: 36281671
[TBL] [Abstract][Full Text] [Related]
17. How acceptable is it for HIV positive African, Caribbean and Black women to provide breast milk/fluid samples for research purposes?
Kapiriri L; Tharao W; Muchenje M; Khatundi IM; Ongoiba F
BMC Res Notes; 2017 Jan; 10(1):7. PubMed ID: 28057074
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the factors influencing African Americans' participation in cancer clinical trials.
Rivers D; August EM; Sehovic I; Lee Green B; Quinn GP
Contemp Clin Trials; 2013 Jul; 35(2):13-32. PubMed ID: 23557729
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Racial/Ethnic Group-Based Medical Mistrust and Perspectives on COVID-19 Vaccine Trial Participation and Vaccine Uptake in the US.
Thompson HS; Manning M; Mitchell J; Kim S; Harper FWK; Cresswell S; Johns K; Pal S; Dowe B; Tariq M; Sayed N; Saigh LM; Rutledge L; Lipscomb C; Lilly JY; Gustine H; Sanders A; Landry M; Marks B
JAMA Netw Open; 2021 May; 4(5):e2111629. PubMed ID: 34042990
[TBL] [Abstract][Full Text] [Related]
20. Using Critical Race Theory to Understand Trial Participation Among Black Individuals With Systemic Lupus Erythematosus: A Qualitative Study of Patients and Caregivers.
Sneed RS; Mason M; Williams JN; Sinnette C; Taber K; Mancera-Cuevas K; Curry G; Canessa P; Ramsey-Goldman R; Feldman CH
Arthritis Care Res (Hoboken); 2021 Oct; 73(10):1387-1395. PubMed ID: 33973413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
